id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-006701-q8qh1kas	Sadeghi, Behnam	Treatment of radiculomyelopathy in two patients with placenta-derived decidua stromal cells	2019-12-18		.txt	text/plain	2343	159	56	We have used placenta-derived decidua stromal cells (DSCs) to treat graft-versus-host disease and found an immunomodulatory and anti-inflammatory effect. The second patient was a 34-year old woman who was admitted 8 months after allogeneic hematopoietic stem cell transplantation due to hemolysis, impaired sensorium below arcus, and difficulty in ambulation. We have used placenta-derived decidua stromal cells (DSCs) for acute and chronic GVHD, ARDS and hemorrhagic cystitis [8] [9] [10] [11] . Electrophysiological investigation following DSCs infusion showed some improvement with more frequent motor unit activity, especially in the right arm. The day after the DSC infusion, she had normal sensation on neurological examination and subjectively in the lower abdomen and legs. The patient was examined with TMS and SEPs every 3-5 months up to a year after the onset of neurological symptoms. Placenta-derived decidua stromal cells for treatment of severe acute graft-versus-host disease	./cache/cord-006701-q8qh1kas.txt	./txt/cord-006701-q8qh1kas.txt